Literature DB >> 11485113

Somatization symptoms and hypochondriacal features in the general population.

W Rief1, A Hessel, E Braehler.   

Abstract

OBJECTIVE: The principal goal of this study is to examine the base rates of somatoform symptoms and of hypochondriacal features in the general population.
METHODS: A representative sample of 2050 persons in Germany was examined by use of screening for somatoform symptoms and the Whiteley Index.
RESULTS: The most frequent somatoform symptoms were back pain, joint pain, pain in extremities, and headache, as well as abdominal symptoms (bloating or intolerance of several foods) and cardiovascular symptoms (palpitation). People reported a mean of two somatization symptoms of DSM-IV somatization disorder (SD) during the prior 2 years. Strong age and medium gender effects were found for most somatoform symptoms, as well as for composite indices. However, the sex ratio suggested in DSM-IV for SD seems to be an overestimation. Hypochondriacal features showed only small sex differences but, again, pronounced age effects. In contrast to low rates for SD, the base rates for somatization and hypochondriacal features were high and represented the health care relevance of subthreshold syndromes.
CONCLUSION: We present base rates of hypochondriacal and somatization features that may be important facets in the development of classification criteria and in the interpretation of health care expenditure.

Entities:  

Mesh:

Year:  2001        PMID: 11485113     DOI: 10.1097/00006842-200107000-00012

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  43 in total

1.  The cost of somatisation among the working-age population in England for the year 2008-2009.

Authors:  Sarah L Bermingham; Alan Cohen; John Hague; Michael Parsonage
Journal:  Ment Health Fam Med       Date:  2010-06

2.  The development and psychometric validation of the central sensitization inventory.

Authors:  Tom G Mayer; Randy Neblett; Howard Cohen; Krista J Howard; Yun H Choi; Mark J Williams; Yoheli Perez; Robert J Gatchel
Journal:  Pain Pract       Date:  2011-09-27       Impact factor: 3.183

3.  The phenomenon of somatization among community Chinese Americans.

Authors:  Winnie W S Mak; Nolan W S Zane
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2004-12       Impact factor: 4.328

4.  Somatization in the population: from mild bodily misperceptions to disabling symptoms.

Authors:  Wolfgang Hiller; Winfried Rief; Elmar Brähler
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2006-06-22       Impact factor: 4.328

5.  [New pain diagnosis in the German version of the ICD-10].

Authors:  W Rief; R-D Treede; U Schweiger; P Henningsen; H Rüddel; P Nilges
Journal:  Nervenarzt       Date:  2009-03       Impact factor: 1.214

6.  Prevalence and correlates of somatoform disorders in the elderly: Results of a European study.

Authors:  Maria Christina Dehoust; Holger Schulz; Martin Härter; Jana Volkert; Susanne Sehner; Anna Drabik; Karl Wegscheider; Alessandra Canuto; Kerstin Weber; Mike Crawford; Alan Quirk; Luigi Grassi; Chiara DaRonch; Manuel Munoz; Berta Ausin; Anna Santos-Olmo; Arieh Shalev; Ora Rotenstein; Yael Hershkowitz; Jens Strehle; Hans-Ulrich Wittchen; Sylke Andreas
Journal:  Int J Methods Psychiatr Res       Date:  2017-02-01       Impact factor: 4.035

Review 7.  Differences in adverse effect reporting in placebo groups in SSRI and tricyclic antidepressant trials: a systematic review and meta-analysis.

Authors:  Winfried Rief; Yvonne Nestoriuc; Anna von Lilienfeld-Toal; Imis Dogan; Franziska Schreiber; Stefan G Hofmann; Arthur J Barsky; Jerry Avorn
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

8.  Long-term course of pain in breast cancer survivors: a 4-year longitudinal study.

Authors:  Winfried Rief; Wayne A Bardwell; Joel E Dimsdale; Loki Natarajan; Shirley W Flatt; John P Pierce
Journal:  Breast Cancer Res Treat       Date:  2011-06-09       Impact factor: 4.872

Review 9.  Lessons learned from placebo groups in antidepressant trials.

Authors:  Meike Shedden Mora; Yvonne Nestoriuc; Winfried Rief
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-06-27       Impact factor: 6.237

10.  Assessing medically unexplained symptoms: evaluation of a shortened version of the SOMS for use in primary care.

Authors:  Cristina Fabião; M C Silva; António Barbosa; Manuela Fleming; Winfried Rief
Journal:  BMC Psychiatry       Date:  2010-05-17       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.